Lucentis gains indication for macular edema after retinal vein occlusion - ONA
Links shared publicly online about this topic.
- 1,073total visits
Lucentis gains indication for macular edema after retinal vein occlusion - ONA
The FDA has approved Lucentis (ranibizumab injection, from Genentech) for the treatment of macular edema following retinal vein occlusion (RVO).
View full resource at oncologynurseadvisor.com
Tags: Circulation, Edema, FDA, Genentech
Most Recently Shared on June 23, 2010 at 3:10 pm By:
Lucentis gains indication for macular edema after retinal vein occlusion http://goo.gl/fb/ikGuE
Advertisement
